Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Hajdu-Cheney Syndrome

Ibtissam Gad, MD, Firas Askar, MD, Sudhaker Rao, MD, & Ayad Alhatib, MD  |  Issue: October 2023  |  October 11, 2023

Hajdu-Cheney syndrome (HCS) is a rare connective tissue disease, with fewer than 100 cases reported worldwide.1 Hallmark features include acro-osteolysis (i.e., resorption of the distal phalanges of the hands and feet), osteoporosis, facial dysmorphisms, and craniofacial and dental abnormalities. Patients often have short stature and can have neuroanatomical deformities causing intellectual disabilities. These patients can also have atrioventricular septal defects and polycystic kidneys. HCS is inherited in an autosomal-dominant pattern and is associated with mutations in the NOTCH-2 protein, although the exact mechanism is still under investigation.1 HCS is not only uncommon, but it can present in various ways, making it important to consider in differential diagnoses of several diseases.

We present the case of a young man with upper and lower extremity joint pain and acro-osteolysis presenting for rheumatic evaluation.

FIGURE 1: Both hands show boutonniere deformities in the third and fourth fingers, with onychorrhexis or longitudinal ridging. (Click to enlarge.)

Case Presentation

Our patient is a 29-year-old man with a past medical history of acro-osteolysis and osteoporosis who presented to our rheumatology clinic with diffuse joint pain. His pain is usually in his right arm in the bicep area and radiates to the forearm. He has associated neuropathy symptoms in both hands. Although his symptoms usually manifest in his right upper extremity, he has had similar symptoms in his left upper and both lower extremities as well. These symptoms occur every few years, persist for a few months and then remit without treatment. He does not have alleviating or aggravating factors and there were no known triggers.

On physical exam, the patient did not have any active synovitis, skin changes or strength deficits. He did have shortened, clubbed digits and flexion deformities of the right fourth and fifth proximal interphalangeal joints. The patient also had a boutonniere deformity in both the third and fourth digits (see Figure 1).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Laboratory studies showed a normal urinalysis and his hemoglobin mildly elevated at 17.7 g/dL (reference range [RR]: 12–15 g/dL). A comprehensive metabolic panel was significant for mildly elevated aspartate transaminase at 43 u/L (RR: 13–39 u/L) and alanine transaminase at 69 u/L (RR: 7/52 u/L). He also had an elevated uric acid at 8.1 mg/dL (RR: 1.5–6.5 mg/dL) and positive anti-mitochondrial M2 antibody at 40.2 u.

FIGURE 2: X-rays of both hands show acro-osteolysis. (Click to enlarge.)

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersOther Rheumatic Conditions Tagged with:acro-osteolysiscase reportHajdu-Cheney syndrome

Related Articles
    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

    crystal light / shutterstock.com

    Rheumatology Case Report: Hand Abnormalities Feature of Fetal Hydantoin Syndrome

    November 6, 2017

    Research has shown that anticonvulsants are teratogens and pose a risk for fetal malformations. Meadow was the first to note a possible link between congenital abnormalities and maternal use of anticonvulsive drug in 1968.1 In 1974, Barr et al noted hypoplasia and irregular ossification of the digital distal phalanges with nail dystrophy in children born to…

    Brandon Crawford / shutterstock.com

    Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

    May 12, 2022

    Cannabis arteritis mirrors thrombo­angiitis obliterans in its clinical and arteriographic presentation, but its relevant exposure is cannabis rather than tobacco.1 Whether cannabis arteritis is a subset of thromboangiitis obliterans or a unique pathologic entity is debatable. Delta-9-tetrahydrocannabinol, the primary psychoactive component of cannabis, is a peripheral vasoconstrictor.2 This offers mechanistic insight into how cannabis may…

    Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

    April 2, 2014

    By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences